Prediction model for assessing HER2 status patient with invasive ductal carcinoma based on clinical parameters and ultrasound features: a dual-center study.

Summary: Doctors need to know if breast cancer has a specific protein called HER2 to pick the best treatment. Usually, this requires a tissue biopsy. In this study, researchers created a new tool that uses standard ultrasound pictures and basic patient details to guess the HER2 status without extra invasive tests. They tested it on 456 patients and found it was highly accurate. This new tool could help doctors quickly and easily figure out the right treatment for breast cancer patients.